Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial
- PMID: 16083996
- DOI: 10.1016/j.clnu.2005.06.006
Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial
Abstract
Background & aims: Growth hormone (GH) has a strong anabolic effect and is thought to be useful in improving the efficacy of parenteral nutrition (PN) to preserve muscle mass (MM) in the postoperative setting. Unfortunately, the negative clinical outcome of GH treatment in intensive care patients limits its use in this setting, but demands answers to the mechanism behind the action of this therapy.
Method: In a double-blind randomised controlled study consecutive patients after major abdominal surgery were divided into four groups of either 1/2-PN (0.13 g N/kg/day and 52% of calories as lipid) or full-strength PN (Full-PN) (0.3 g N/kg/day and 65% of calories as lipid) receiving daily injections of either GH (8-16 IU) or placebo for a period of 14 days postoperative. Outcome measures included MM derived from measures of total body potassium (40K counting) and total body nitrogen (TBN) (in vivo neutron capture technique); Fat mass from skin folds; serum insulin like growth factor-I (IGF-I) and its binding proteins (IGFBP).
Results: From 43 major upper GI surgical patients randomised 35 completed the study (one patient died from sepsis in the half-strength PN (1/2-PN)+GH group). 1/2-PN (n=11) lost TBN (P=0.001), MM (P=0.005) but not fat. Full-PN (n=9) maintained TBN, MM (P=0.056) and fat. 1/2-PN+GH (n=8) maintained TBN and fat but lost MM (P=0.038). Full-PN+GH (n=7) maintained TBN and MM but lost fat (P=0.018). Two-way ANOVA indicated that PN input (P=0.031) and not GH had a significant effect on MM. GH caused a significant rise in IGF-I levels (290+/-67 and 454+/-71 microg/l for 1/2-PN+GH and Full-PN+GH, respectively) and restored serum IGFBP3 and the acid labile subunit to normal, by the postoperative day 9.
Conclusion: After major gastrointestinal surgery, GH causes a marked hepatic IGF-I response and nitrogen retention but its effect on body composition was more significant with a high PN input. Further, Full-PN alone was sufficient to prevent nitrogen loss and preserved MM and addition of GH does not provide further metabolic advantage.
Similar articles
-
Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.Clin Nephrol. 1999 Aug;52(2):103-9. Clin Nephrol. 1999. PMID: 10480221 Clinical Trial.
-
Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.Clin Nephrol. 2000 Feb;53(2):99-107. Clin Nephrol. 2000. PMID: 10711411 Clinical Trial.
-
Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001. Epub 2008 Feb 20. Growth Horm IGF Res. 2008. PMID: 18282776 Clinical Trial.
-
Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients.Semin Respir Infect. 1994 Dec;9(4):240-7. Semin Respir Infect. 1994. PMID: 7886321 Review.
-
Effects of insulin-like growth factor-I and growth hormone in models of parenteral nutrition.JPEN J Parenter Enteral Nutr. 1999 Nov-Dec;23(6 Suppl):S184-9. doi: 10.1177/014860719902300603. JPEN J Parenter Enteral Nutr. 1999. PMID: 10571453 Review.
Cited by
-
Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery.World J Gastroenterol. 2007 Apr 21;13(15):2223-8. doi: 10.3748/wjg.v13.i15.2223. World J Gastroenterol. 2007. PMID: 17465506 Free PMC article. Clinical Trial.
-
Effect of growth hormone, hyperbaric oxygen and combined therapy on the gastric serosa.World J Gastroenterol. 2013 May 21;19(19):2904-12. doi: 10.3748/wjg.v19.i19.2904. World J Gastroenterol. 2013. PMID: 23704823 Free PMC article.
-
Interventions for preventing critical illness polyneuropathy and critical illness myopathy.Cochrane Database Syst Rev. 2014 Jan 30;2014(1):CD006832. doi: 10.1002/14651858.CD006832.pub3. Cochrane Database Syst Rev. 2014. PMID: 24477672 Free PMC article.
-
Optimal nutrition during the period of mechanical ventilation decreases mortality in critically ill, long-term acute female patients: a prospective observational cohort study.Crit Care. 2009;13(4):R132. doi: 10.1186/cc7993. Epub 2009 Aug 11. Crit Care. 2009. PMID: 19671136 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous